The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues
暂无分享,去创建一个
L. Pusztai | W. Symmans | C. Hatzis | R. Lau | Alexander J. Trevarton | B. Sinn | R. Gould | M. Marczyk | Chunxiao Fu | L. Du | Alexander J Trevarton | Michał Marczyk
[1] Kuanyu Wang,et al. A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level , 2020, Journal of Cancer Research and Clinical Oncology.
[2] A. Viale,et al. SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer , 2019, npj Breast Cancer.
[3] E. Domany,et al. mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues , 2018, BMC Genomics.
[4] Christian G Bien,et al. Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples , 2018, Scientific Reports.
[5] T. Speed,et al. Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue to Represent High-Quality Transcriptome From Frozen Tissue , 2018, JCO precision oncology.
[6] Chungyeul Kim,et al. Optimization of RNA Extraction from Formalin-Fixed Paraffin-Embedded Blocks for Targeted Next-Generation Sequencing , 2017, Journal of breast cancer.
[7] P. Simpson,et al. Molecular signatures in breast cancer. , 2017, Methods.
[8] S. Schuierer,et al. A comprehensive assessment of RNA-seq protocols for degraded and low-quantity samples , 2017, BMC Genomics.
[9] S. Heath,et al. A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples , 2017, PloS one.
[10] Na Li,et al. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples , 2016, Oncotarget.
[11] Joel S. Parker,et al. Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer , 2016, Bioinform..
[12] J. Carpten,et al. Translating RNA sequencing into clinical diagnostics: opportunities and challenges , 2016, Nature Reviews Genetics.
[13] Ying Li,et al. Measure transcript integrity using RNA-seq data , 2016, BMC Bioinformatics.
[14] Christoph Ziegenhain,et al. The impact of amplification on differential expression analyses by RNA-seq , 2016, Scientific Reports.
[15] Peter Beyerlein,et al. Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples , 2015, Scientific Reports.
[16] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[17] C. Sotiriou,et al. Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology , 2014, BMC Genomics.
[18] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[19] Sheng Li,et al. Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study , 2014, Nature Biotechnology.
[20] David P. Kreil,et al. A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control consortium , 2014, Nature Biotechnology.
[21] D. Bates,et al. Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.
[22] Anne-Mette K. Hein,et al. Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue , 2014, PloS one.
[23] Y. Gilad,et al. RNA-seq: impact of RNA degradation on transcript quantification , 2014, BMC Biology.
[24] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[25] Krishna R. Kalari,et al. Gene Expression, Single Nucleotide Variant and Fusion Transcript Discovery in Archival Material from Breast Tumors , 2013, PloS one.
[26] Aviv Regev,et al. Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples , 2013, Nature Methods.
[27] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[28] Wei Li,et al. RSeQC: quality control of RNA-seq experiments , 2012, Bioinform..
[29] L. Pusztai,et al. Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers. , 2011, Journal of the National Cancer Institute.
[30] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[31] R. Greil,et al. A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors , 2011, Clinical Cancer Research.
[32] Peter Regitnig,et al. Genomic index of sensitivity to endocrine therapy for breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] T. Eberlein. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer , 2006 .
[34] Charles Auffray,et al. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces , 2005, Nucleic acids research.
[35] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[36] L. Lin,et al. A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.